Skip to main content

Month: August 2022

Liquidia Provides Update on Hatch-Waxman Litigation and to Host Call on September 1, 2022, at 8:00am E.T.

District Court ruling was favorable on ‘066 patent and unfavorable on ‘793 patent All patent claims asserted have been found to be either invalid or not infringed by District Court or U.S. Patent Trial and Appeal Board (PTAB) PTAB decision to invalidate all claims of ‘793 patent is not affected Ability to seek final FDA approval of YUTREPIA™ (treprostinil) inhalation powder is contingent on affirmation of the PTAB decision or reversal of District Court decision regarding the ‘793 patentMORRISVILLE, N.C., Aug. 31, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) announced today that a ruling was issued by Judge Andrews, who is presiding over the litigation filed by United Therapeutics Corporation (UTC) in the United States District Court for the District of Delaware under the Drug Price Competition and Patent Term...

Continue reading

Black Diamond Group Limited releases inaugural Corporate Responsibility Report

CALGARY, Alberta, Aug. 31, 2022 (GLOBE NEWSWIRE) — Black Diamond Group Limited (“Black Diamond” or the “Company”) (TSX: BDI), a leading provider of space rental and workforce accommodation, today released its inaugural Corporate Responsibility Report. The Report details the Company’s commitment to environmental, social and governance issues and is a key component to how the Company continues To Create a Better Way for its stakeholders. “We are excited to announce the launch of Black Diamond Group’s first Corporate Responsibility Report,” states Trevor Haynes, Chairman & CEO of Black Diamond Group. “Since our inception in 2003, we have strived to be a leader in operating conscientiously, through the responsible use of resources and reliable compliance to local regulations. Additionally, we have always sought to give back...

Continue reading

ConnectWise Announces Acquisition of Wise-Sync

ConnectWise partners to benefit from an integrated payment processing platform built into ConnectWise Manage and now, ConnectWise Sell TAMPA, Fla., Aug. 31, 2022 (GLOBE NEWSWIRE) — ConnectWise, the world’s leading software company dedicated to the success of IT solution providers, today announced it has acquired Wise-Sync, an integrated payment automation platform and long-term partner in the ConnectWise ecosystem. The acquisition will pair ConnectWise’s best-in-class IT solution provider (TSP) software and services platform with cutting-edge payment processing and invoicing automation functionality. Designed originally when founder, Paul MacNeill, saw a need to ease the challenge of automating the collection of payments, Wise-Sync is an integration that allows TSPs to improve cash flow, remove painful errors, and allow businesses...

Continue reading

HP Announces Expiration and Final Results of Exchange Offer for Plantronics Notes

PALO ALTO, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) — HP Inc. (NYSE: HPQ) (“HP” or the “Company”) announced today the expiration and final results of the previously announced offer to exchange (the “Exchange Offer”) any and all outstanding notes (the “Poly Notes”) of Plantronics, Inc. (“Poly”) for up to $500,000,000 aggregate principal amount of new notes to be issued by the Company (the “HP Notes”). The Exchange Offer expired at 5:00 p.m., New York City time, on August 31, 2022 (the “Expiration Date”). For each $1,000 principal amount of Poly Notes validly tendered and not validly withdrawn prior to the Expiration Date, eligible holders of Poly Notes will receive $1,000 principal amount of HP Notes. For each $1,000 principal amount of Poly Notes validly tendered and not validly withdrawn at or prior to the Early Participation Date...

Continue reading

Mercury introduces rugged data storage system that enables faster access and exploitation of big data at the edge with reduced sustainment costs

Data center-class all-flash network-attached storage system for mission-critical AI and machine learning applicationsMercury Rugged Data Storage system Mercury’s new Rugged Data Storage (RDS) system is a data center-class, all-flash network-attached storage (NAS) system that is ruggedized for mission-critical aerospace, defense, and commercial edge applications and designed for low-latency, scalability, and security.ANDOVER, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) — Mercury Systems Inc. (NASDAQ: MRCY, www.mrcy.com), a leader in trusted, secure mission-critical technologies for aerospace and defense, today announced the new Rugged Data Storage (RDS) system. The data center-class, all-flash network-attached storage (NAS) system is ruggedized for mission-critical aerospace, defense, and commercial edge applications and is...

Continue reading

Brady Corporation increases its dividend to shareholders for the 37th consecutive year

MILWAUKEE, Aug. 31, 2022 (GLOBE NEWSWIRE) — On August 30, 2022, Brady Corporation’s (NYSE: BRC) Board of Directors approved an increase in the annual dividend to shareholders of the Company’s Class A Common Stock from $0.90 per share to $0.92 per share. A quarterly dividend to shareholders of the Company’s Class A Common Stock of $0.23 per share will be paid on October 28, 2022, to shareholders of record at the close of business on October 7, 2022. This dividend represents the 37th consecutive annual increase in dividends.   Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places. Brady’s products help customers increase safety, security, productivity and performance and include high-performance labels, signs, safety devices, printing systems and...

Continue reading

Plains All American’s 2021 Schedule K-3 Now Available

HOUSTON, Aug. 31, 2022 (GLOBE NEWSWIRE) — Plains All American Pipeline, L.P. (Nasdaq: PAA) (the “Partnership”) today announced that its 2021 Schedule K-3 reflecting items of international tax relevance is available online. Unitholders requiring this information may access their Schedules K-3 at www.taxpackagesupport.com/plainsallamerican. A limited number of unitholders (primarily foreign unitholders, unitholders computing a foreign tax credit on their tax return and certain corporate and/or partnership unitholders) may need the detailed information disclosed on Schedule K-3 for their specific reporting requirements.  To the extent Schedule K-3 is applicable to your federal income tax return filing needs, we encourage you to review the information contained on this form and refer to the appropriate federal laws and guidance or...

Continue reading

Interpace Biosciences Completes Sale of Its Pharma Services Business to Flagship Biosciences, Inc.

Interpace Transitions to focused Molecular Diagnostics Business Disposition of Pharma Services Expected to Improve Operating Cash Flow by nearly $5 million AnnuallyPARSIPPANY, NJ, Aug. 31, 2022 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”), a leader in enabling personalized medicine, has announced the closing of a definitive asset purchase agreement under which Flagship Biosciences, Inc. has acquired the Company’s Pharma Services business (Interpace Pharma Solutions). The Company will use the proceeds from the transaction for working capital requirements and investments to help drive the growth of its molecular diagnostics business. “With the completion of the transaction, we expect the Company’s operating cash flow to improve by nearly $5 million annually. We will be a focused...

Continue reading

Imperial Closes $47 Million Non-Brokered Private Placement of Convertible Debentures

VANCOUVER, British Columbia, Aug. 31, 2022 (GLOBE NEWSWIRE) — Imperial Metals Corporation (the “Company” or “Imperial”) (TSX:III) is pleased to announce that further to its news release dated August 5, 2022, the Company has closed its non-brokered private placement (the “Private Placement”) of unsecured convertible debentures (the “Convertible Debentures”) with an aggregate principal amount of $47 million, up from the $45 million previously announced. Each $3.20 of the principal amount of the Convertible Debentures is convertible into one common share of the Company. The Convertible Debentures are not callable unless the closing price of the Company’s common shares exceeds 140% of the conversion price for at least 30 consecutive days. Interest at 8% per annum will be payable semi-annually with the first payment due on February...

Continue reading

Alvotech Reports First Half 2022 Financial Results and Business Update

Secured funding of approximately $185 million in gross proceeds through the merger with OACB (the “Business Combination”) and private placement investment in public equity (PIPE) financing Debuted as publicly-traded company on Nasdaq Stock Exchange in U.S. and on Nasdaq First North Market in Iceland; Board approved plan to move Iceland listing to Nasdaq Main Market Revenues for first half 2022 increased to $40 million driven by revenue from milestones related to pipeline progress and recent launches of AVT02 (adalimumab) in Canada and certain European markets Continued progress of the pipeline, including becoming the 2nd company to report positive topline results from a patient study for a proposed biosimilar to Stelara® Management to conduct a business update conference call and live webcast on Thursday, September 1, 2022, at 8:00 am...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.